Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 292 results found. Search for [ Aurobindo Pharma ]

Results 280 to 292 of 292
E. Kumar Sharma
August 18, 2011
At 75, Cipla is in fine fettle but its chairman faces challenges that are very different from those of the past.


R. Shree Ram
December 24, 2010
The second quarter results for 2010-11 indicate that the Indian markets have bounced back, with most companies exceeding analysts' expectations.


R. Sree Ram
December 4, 2009
The roller-coaster journey of the stock markets this year has taught the small investor never to give up on this asset class.


R. Sree Ram
January 22, 2009
Investing in select pharma stocks might be the shot in the arm that your portfolio needs in times of a slowdown. The general environment for the pharma industry, particularly for domestic companies, seems positive.


By Dipen Sheth
October 4, 2007
With volatility ebbing from the markets, it is time to stay put with our pickings, but with minor changes.


www.businesstoday.in
March 22, 2007
The industry has hiked prices to pass on a dual-rate excise hike. Earnings will dip 15% without the hike.


By Devangshu Datta
March 22, 2007
There is still scope for growth in stock prices, but don’t expect your portfolio to go ballistic in 2007.


E. Kumar Sharma
July 22, 2010
Multinationals are closing in on Big Pharma, but there are enough mid-size stars as well.


E. Kumar Sharma
June 9, 2010
Piramal's domestic formulations business becomes the latest—and most expensive—acquisition of an Indian drug business by a global pharma major. As the stakes get higher, who's next?


E. Kumar Sharma
April 14, 2010
The historic reform in the US healthcare system spells a boon for India's pharma, IT and BPO industries.


E. Kumar Sharma
August 19, 2009
By refocussing its strategies, Natco Pharma has pulled back from the brink of bankruptcy to power ahead in cancer drugs. Now it is looking for niche areas globally. Can it scale up and take on global competition?


www.businesstoday.in
August 6, 2008
After Daiichi Sankyo’s purchase of Ranbaxy Labs, Teva Pharma, the world’s largest generics company, acquired Barr Pharma, the US’ fourth largest generics firm. There are two questions on pharma analysts’ lips these days: Who’s next? Are Indian generics players targets for pharma MNCs?


By Pallavi Srivastava
October 17, 2007
After capturing a huge chunk of the outsourced financial services market, traditional IT services companies are now gunning for the healthcare and pharmaceuticals segment—the largest industry in the US and the second-largest outsourcer after financial services.


PAGES 15 OF 15  1112131415